OrbiMed Advisors »

ADC Therapeutics SA shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $14M 4.3M 3.16

More positions owned by OrbiMed Advisors

Sinovac Biotech SHS (SVA)
Eli Lilly & Co. (LLY)
Edgewise Therapeutics (EWTX)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Biogen Idec (BIIB)
Enliven Therapeutics (ELVN)
Merck & Co (MRK)
Tenet Healthcare Corp Com New (THC)
Janux Therapeutics (JANX)
Ionis Pharmaceuticals (IONS)
Sarepta Therapeutics (SRPT)
Stryker Corporation (SYK)
Anthem (ELV)
Argenx Se Sponsored Adr (ARGX)

View all positions for OrbiMed Advisors

Top funds holding ADC Therapeutics SA

Redmile Group
Prosight Management
OrbiMed Advisors
BlackRock
Morgan Stanley
Silverarc Capital Management
Goldman Sachs Group
Bank of America Corporation
Artal Group
Adage Capital Partners GP
State Street Corporation
Millennium Management
Vantage Consulting Group
Geode Capital Management
Blue Owl Capital Holdings

View all funds holding ADC Therapeutics SA